Y.S.P.SOUTHEAST ASIA HOLDING
KLSE: 7178 (YSPSAH)
Last update: 5 hours ago2.06
-0.04 (-1.90%)
| Previous Close | 2.10 |
| Open | 2.15 |
| Volume | 8,400 |
| Avg. Volume (3M) | 22,835 |
| Market Cap | 292,200,672 |
| Price / Earnings (TTM) | 10.84 |
| Price / Sales | 0.810 |
| Price / Book | 0.730 |
| 52 Weeks Range | |
| TTM Dividend Yield | 5.34% |
| Profit Margin | 7.24% |
| Operating Margin (TTM) | 10.22% |
| Diluted EPS (TTM) | 0.190 |
| Quarterly Revenue Growth (YOY) | 8.30% |
| Quarterly Earnings Growth (YOY) | -24.10% |
| Total Debt/Equity (MRQ) | 12.82% |
| Current Ratio (MRQ) | 5.70 |
| Operating Cash Flow (TTM) | 49.71 M |
| Levered Free Cash Flow (TTM) | 26.47 M |
| Return on Assets (TTM) | 4.75% |
| Return on Equity (TTM) | 6.61% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (MY) | Mixed | Mixed |
| Drug Manufacturers - Specialty & Generic (Global) | Mixed | Mixed | |
| Stock | YSPSAH | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | 4.0 |
| Price Volatility | 3.5 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | -2.5 |
| Average | 0.50 |
|
Y.S.P. Southeast Asia Holding Bhd is an investment company, that engages in the pharmaceutical business, and provision of management services. It operates through the following segments: Trading, Manufacturing, and Investment Holding. The Trading segment imports, exports, and trades various kinds of pharmaceutical products, and traditional herbal and veterinary products. The Manufacturing segment manufactures pharmaceutical products. The Investment Holding segment focuses on investment holding activity. The firm's majority of revenue comes from the Manufacturing segment. The majority of revenue is concentrated in Malaysia. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Value |
| % Held by Insiders | 66.79% |
| % Held by Institutions | 0.93% |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| MR CHIN CHEW MUN | 2.02 | - | 20,000 | 40,400 |
| DATO' DR LEE FANG HSIN | 2.19 | - | 200,000 | 438,000 |
| Aggregate Net Quantity | 220,000 | |||
| Aggregate Net Value ($) | 478,400 | |||
| Aggregate Avg. Buy ($) | 2.13 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| MR CHIN CHEW MUN | Director | 07 Apr 2025 | Acquired (+) | 20,000 | 2.02 | 40,400 |
| DATO' DR LEE FANG HSIN | Director | 03 Apr 2025 | Acquired (+) | 100,000 | 2.19 | 219,000 |
| DATO' DR LEE FANG HSIN | Substantial Shareholder | 03 Apr 2025 | Acquired (+) | 100,000 | 2.19 | 219,000 |
| TTM Dividend Yield | 5.34% |
| 5Y Average Dividend Yield | 3.98% |
| Payout Ratio | 42.53% |
| Expected Next Dividend Payment | Jul 2025 |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2024 | 0.110 | 1 | 4.78 |
| 2023 | 0.100 | 1 | 4.35 |
| 2022 | 0.080 | 1 | 3.14 |
| 2021 | 0.080 | 1 | 4.15 |
| 2020 | 0.080 | 1 | 3.51 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |